1. Home
  2. GBIO vs WAI Comparison

GBIO vs WAI Comparison

Compare GBIO & WAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • WAI
  • Stock Information
  • Founded
  • GBIO 2016
  • WAI 2018
  • Country
  • GBIO United States
  • WAI China
  • Employees
  • GBIO N/A
  • WAI N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • WAI
  • Sector
  • GBIO Health Care
  • WAI
  • Exchange
  • GBIO Nasdaq
  • WAI NYSE
  • Market Cap
  • GBIO 29.2M
  • WAI 8.1M
  • IPO Year
  • GBIO 2020
  • WAI 2023
  • Fundamental
  • Price
  • GBIO $0.44
  • WAI $0.48
  • Analyst Decision
  • GBIO Strong Buy
  • WAI
  • Analyst Count
  • GBIO 4
  • WAI 0
  • Target Price
  • GBIO $7.33
  • WAI N/A
  • AVG Volume (30 Days)
  • GBIO 1.2M
  • WAI 1.8M
  • Earning Date
  • GBIO 08-06-2025
  • WAI 08-24-2025
  • Dividend Yield
  • GBIO N/A
  • WAI N/A
  • EPS Growth
  • GBIO N/A
  • WAI N/A
  • EPS
  • GBIO N/A
  • WAI N/A
  • Revenue
  • GBIO $24,556,000.00
  • WAI $3,750,352.00
  • Revenue This Year
  • GBIO N/A
  • WAI N/A
  • Revenue Next Year
  • GBIO N/A
  • WAI N/A
  • P/E Ratio
  • GBIO N/A
  • WAI N/A
  • Revenue Growth
  • GBIO 146.47
  • WAI N/A
  • 52 Week Low
  • GBIO $0.30
  • WAI $0.43
  • 52 Week High
  • GBIO $3.65
  • WAI $20.00
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 63.54
  • WAI N/A
  • Support Level
  • GBIO $0.32
  • WAI N/A
  • Resistance Level
  • GBIO $0.36
  • WAI N/A
  • Average True Range (ATR)
  • GBIO 0.03
  • WAI 0.00
  • MACD
  • GBIO 0.01
  • WAI 0.00
  • Stochastic Oscillator
  • GBIO 93.40
  • WAI 0.00

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About WAI TOP KINGWIN LTD

Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).

Share on Social Networks: